# Solving Riddles Through Sequencing

> **NCT05046444** · — · RECRUITING · sponsor: **Munich Leukemia Laboratory** · enrollment: 100 (estimated)

## Conditions studied

- Leukemia
- Hematologic Malignancy
- Rare Diseases
- Refractory Leukemia
- Refractory Lymphoma
- Unknown Primary Tumors

## Interventions

- **DIAGNOSTIC_TEST:** Next Generation Sequencing

## Key facts

- **NCT ID:** NCT05046444
- **Lead sponsor:** Munich Leukemia Laboratory
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-19
- **Primary completion:** 2025-08-31
- **Final completion:** 2026-10-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05046444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05046444, "Solving Riddles Through Sequencing". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05046444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*